FDA Approves GSK's Pentavalent Meningococcal Vaccine Dr. Kamal Kant Kohli18 Feb 2025 9:00 PM ISTThe US Food and Drug Administration (FDA) has approved GSK's pentavalent meningococcal vaccine, Penmenvy, for children and young adults aged 10 to 25...
GSK's Meningococcal Vaccine Penmenvy Approved by USFDA Farhat Nasim17 Feb 2025 5:19 PM ISTBengaluru: The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for...
GSK fully liquid Menveo meningococcal vaccine approved by European Commission Ruchika Sharma29 Nov 2024 12:39 PM ISTLondon: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of...
USFDA accepts for review GSK 5-in-1 meningococcal ABCWY vaccine candidate Ruchika Sharma17 April 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
GSK declares positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine Ruchika Sharma15 March 2023 5:30 PM ISTLondon: GSK plc has announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity...
USFDA nod to GSK Menveo in new single-vial presentation to prevent invasive meningococcal disease Ruchika Sharma18 Oct 2022 10:00 AM IST"The Menveo one-vial presentation now comes in a ready to use single vial giving healthcare providers a more convenient option," GSK stated.
